Top

Intensive Care Medicine

Published in:

01-07-2004 | Neonatal and Pediatric Intensive Care

Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein

Authors: Maja Pavcnik-Arnol, Sergej Hojker, Metka Derganc

Published in: Intensive Care Medicine | Issue 7/2004

Abstract

Objective

To evaluate markers of infection in critically ill neonates and children, comparing lipopolysaccharide-binding protein (LBP) with procalcitonin (PCT), interleukin-6 (IL-6), and C-reactive protein (CRP).

Design and setting

Prospective, observational study in the level III multidisciplinary neonatal and pediatric intensive care unit.

Patients

Sixty patients with systemic inflammatory response syndrome (SIRS) and suspected infection classified into two groups: SIRS/sepsis (n=33) and SIRS/no sepsis (n=27). We included 29 neonates aged less than 48 h (neonates <48 h), 12 neonates older than 48 h (neonates >48 h), and 19 children. Median disease severity was high in neonates aged under 48 h and moderate in neonates aged over 48 h and children.

Interventions

Serum LBP, PCT, IL-6, and CRP were measured on two consecutive days. Area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and predictive values were evaluated.

Results

Serum LBP was higher in patients with SIRS/sepsis than in patients with SIRS/no sepsis. AUC for LBP on the first day of suspected infection was 0.89 in the younger neonates, 0.93 in the older neonates, and 0.91 in children.

Conclusions

In critically ill neonates aged under 48 h LBP on the first day of suspected infection is a better marker of sepsis than IL-6 and PCT, and is similar to CRP. In critically ill neonates aged over 48 h and children LBP is a better marker than IL-6 and CRP, and is similar to PCT.

Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874

Proulx F, Fayon M, Farrell Ca, Lacroix J, Gauthier M (1996) Epidemiology of sepsis and multiple dysfunction syndrome in children. Chest 109:1033–1037

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G for the International Sepsis Definitions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530–538

Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L (1998) Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 26:664–672

Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J (1998) Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin Infect Dis 27:1559–1560

Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL (1998) Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 351:1211–1212

Bonac B, Derganc M, Wraber B, Hojker S (2000) Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates. Pflugers Arch 440 [Suppl 5]:R72–R74

Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA (1999) Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 81:417–421

Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA (2001) Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 27:211–215

10.

Casado-Flores J, Blanco-Quiros A, Asensio J, Arranz E, Garrote JA, Nieto M (2003) Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 4:190–195

11.

Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429–1430

12.

White ML, Ma JK, Mendoza NT, Dedrick RL, Carroll SF (1995) Differential acute phase response between subjects with inflammatory, infectious and non-infectious diseases. Abstracts of the 35thICAAC, p.77

13.

Froon AHM, Dentener MA, Willem J, Greve M, Ramsay G, Buurman WA (1995) Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis 171:1250–1257

14.

Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–1589

15.

Blairon L, Wittebole X, Laterre PF (2003) Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis 187:287–291

16.

Kaden J, Zwerenz P, Lambrecht HG, Dostatni R (2002) Lipopolysaccharide-binding protein as a new and reliable infection marker after kidney transplantation. Transpl Int 15:163–172

17.

Berner R, Furll B, Stelter F, Drose J, Muller HP, Schutt C (2002) Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol 9:440–445

18.

Oude Nijhuis CSM, Vellenga E, Daenen SMGJ, van der Graaf WTA, Gietema JA, Groen HJM, Kamps WA, de Bont ESJM (2003) Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med (http://dx.doi.org/10.1007/s00134-003-2026-2)

19.

Despond O, Proulx F, Carcillo JA, Lacroix J (2001) Pediatric sepsis and multiple organ dysfunction syndrome. Curr Opin Pediatr 13:247–253

20.

Martinot A, Leclerc F, Cremer R. Leteurtre S, Fourier C, Hue V (1997) Sepsis in neonates and children: definitions, epidemiology, and outcome. Pediatr Emerg Care 13:277–281

21.

Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24:743–752

22.

Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843

23.

Schumann RR, Zweigner J (1999) A novel acute-phase marker: lipopolysaccharide-binding protein. Clin Chem Lab Med 37:271–274

24.

Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D (1997) The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4:113–116

25.

Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, Giroir BP (2000) Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 117:1706–1712

26.

Proulx F, Seldman E, Mariscalco MM, Lee K, Caroll S (1999) Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome. Clin Diagn Lab Immunol 6:773

27.

Takeshita S, Tsujimoto H, Kawase, Kawamura Y, Sekine I (2002) Increased levels of lipopolysaccharide binding protein in plasma in children with Kawasaki disease. Clin Diagn Lab Immunol 9:205–206

28.

Orlikowsky T, Schumacher C, Deperschmidt N, Henkel C, Niethammer D, Goelz R (2001) Lipopolysaccharid (LPS)-bindendes Protein (LBP) im Plasma von gesunden Neugeborenen und Neugeborenen mit neonataler bakterieller Infektion. Z Geburtshilfe Neonatol 205 [Suppl1]:S26–S27

29.

Sablotzki A, Borgermann J, Baulig W, Friedrich I, Spillner J, Silber RE, Czeslick E (2001) Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Thorac Cardiovasc Surg 49:273–278

30.

Weber JR, Freyer D, Alexander C, Schroder NWJ, Reiss A, Kuster C, Pfeil D, Tuomanen EI, Schumann RR (2003) Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19:269–279

31.

Gendrel D, Bohuon C (2000) Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 19:679–688

32.

Lepper PM, Held TK, Schneider EM, Bolke E, Gerlach H, Trautmann M (2002) Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 28:824–833

Title: Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein
Authors: Maja Pavcnik-Arnol
Sergej Hojker
Metka Derganc
Publication date: 01-07-2004
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 7/2004
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-004-2307-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein

Abstract

Objective

Design and setting

Patients

Interventions

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objective

Design and setting

Patients

Interventions

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2004

Assessment of peri-extubation pain by visual analogue scale in the adult intensive care unit: a prospective observational study

Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma

Heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheep

Reply to the comment by Skrobik et al.

Introducing Critical Care Outreach: a ward-randomised trial of phased introduction in a general hospital

Looking at subgroups in an inhomogeneous population does not make these subgroups more homogeneous